Goldman Sachs’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,374,383
| Closed | -$3.02M | – | 5542 |
|
|
2020
Q4 | $3.02M | Sell |
4,374,383
-535,342
| -11% | -$369K | ﹤0.01% | 2810 |
|
|
2020
Q3 | $11M | Sell |
4,909,725
-305,597
| -6% | -$688K | ﹤0.01% | 1883 |
|
|
2020
Q2 | $18.7M | Sell |
5,215,322
-614,760
| -11% | -$2.2M | 0.01% | 1515 |
|
|
2020
Q1 | $22.2M | Buy |
5,830,082
+181,881
| +3% | +$691K | 0.01% | 1259 |
|
|
2019
Q4 | $17M | Buy |
+5,648,201
| New | +$17M | ﹤0.01% | 1724 |
|